# Novo Nordisk Pharmaceutical Industries LP - Inspection Records Source: https://www.keypedia.com/companies/novo-nordisk-pharmaceutical-industries-lp/ae9a8861-e1ab-4878-a69f-e2f23284d455 > Inspection records and compliance data for Novo Nordisk Pharmaceutical Industries LP in Clayton, North Carolina. Access full analysis and detailed observations. --- ## Details - Name: Novo Nordisk Pharmaceutical Industries LP - FEI Number: 1000158576 - City: Clayton - State: North Carolina - Country Name: United States - Address Line 1: 3612 Powhatan Rd - Zip Code: 27527 - Facility Type: API Manufacturer ## Related Documents - [FDA Inspection 1269778 - Novo Nordisk Pharmaceutical Industries LP - 2025-06-13](https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/0f9197b3-27be-4116-af74-51f7d60953ec) — source: FDA, date: June 13, 2025 - [EIR - Novo Nordisk Pharmaceutical Industries LP - 2023-07-13](https://www.keypedia.com/records/eir/novo-nordisk-pharmaceutical-industries-lp/272bae5d-2bf6-49db-a557-0b48425a5816) — source: FDA, date: July 13, 2023 - [483 - Novo Nordisk Pharmaceutical Industries LP - 2023-07-13](https://www.keypedia.com/records/483/novo-nordisk-pharmaceutical-industries-lp/07f68227-1226-420a-b605-fb4e3475849f) — source: FDA, date: July 13, 2023 - [FDA Inspection 1214533 - Novo Nordisk Pharmaceutical Industries LP - 2023-07-13](https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/749be7fc-b19e-47bd-b9e8-d343f00c62d6) — source: FDA, date: July 13, 2023 - [483 - Novo Nordisk Pharmaceutical Industries LP - 2023-07-06](https://www.keypedia.com/records/483/novo-nordisk-pharmaceutical-industries-lp/281bc5eb-3b36-4b84-8126-0d6364b9f962) — source: FDA, date: July 6, 2023 - [EIR - Novo Nordisk Pharmaceutical Industries LP - 2022-05-13](https://www.keypedia.com/records/eir/novo-nordisk-pharmaceutical-industries-lp/37bcd4d9-2dd4-4e51-9349-32184213bfa8) — source: FDA, date: May 13, 2022 - [483 - Novo Nordisk Pharmaceutical Industries LP - 2022-05-09](https://www.keypedia.com/records/483/novo-nordisk-pharmaceutical-industries-lp/83be62a1-a352-4d5a-a220-8eb28ceb43b9) — source: FDA, date: May 9, 2022 - [FDA Inspection 1041878 - Novo Nordisk Pharmaceutical Industries LP - 2018-01-12](https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/308f9d1f-49c5-4927-b3a6-951b179eb998) — classification: No Action Indicated (NAI), source: FDA, date: January 12, 2018 - [FDA Inspection 1035563 - Novo Nordisk Pharmaceutical Industries LP - 2016-01-28](https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/fd8b82a1-b715-4641-a020-8473d31ee0b6) — classification: No Action Indicated (NAI), source: FDA, date: January 28, 2016 - [FDA Inspection 892098 - Novo Nordisk Pharmaceutical Industries LP - 2014-08-21](https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/9bc25a36-afc3-4342-96ab-19bc691f8c71) — classification: No Action Indicated (NAI), source: FDA, date: August 21, 2014 - [FDA Inspection 802592 - Novo Nordisk Pharmaceutical Industries LP - 2012-08-16](https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/c75d01c5-b818-41c9-92a2-e7487cb91267) — classification: No Action Indicated (NAI), source: FDA, date: August 16, 2012 - [FDA Inspection 734383 - Novo Nordisk Pharmaceutical Industries LP - 2011-07-01](https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/27cf4df6-dc42-425b-872a-9e42a0a88500) — classification: No Action Indicated (NAI), source: FDA, date: July 1, 2011 - [FDA Inspection 678990 - Novo Nordisk Pharmaceutical Industries LP - 2010-09-03](https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/3fd97a2d-0209-4487-a089-abdcb582c5b1) — classification: No Action Indicated (NAI), source: FDA, date: September 3, 2010 - [FDA Inspection 618646 - Novo Nordisk Pharmaceutical Industries LP - 2009-09-02](https://www.keypedia.com/records/fda_inspections/novo-nordisk-pharmaceutical-industries-lp/d4a23119-3ded-419a-a3ad-d626e8acd7e4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 2, 2009 ## Related Companies - [Medinatura New Mexico, inc.](https://www.keypedia.com/companies/medinatura-new-mexico-inc/9ac6fb13-d04a-47c0-984a-ed542030da80) - [Alto ICP, LLC](https://www.keypedia.com/companies/alto-icp-llc/bc6bac2f-8575-40c1-a90c-25f152eb71fd) - [Curium US PET LLC](https://www.keypedia.com/companies/curium-us-pet-llc/0bdd3dc2-1a8a-46ec-819b-0a1d58ac2e15) - [Zhejiang Jinhua Conba Bio-Pharm. Co., Ltd.](https://www.keypedia.com/companies/zhejiang-jinhua-conba-bio-pharm-co-ltd/ccf6fb2b-5de1-4f70-903b-d442374003f6) - [OHM Pharma, Inc.](https://www.keypedia.com/companies/ohm-pharma-inc/c3ecfcf1-4d7d-4404-be13-ea1bdc864d14) - [American Spraytech LLC](https://www.keypedia.com/companies/american-spraytech-llc/fc33eb75-e75e-42fd-b6a5-a042d486fb23) - [Honour Lab Limited](https://www.keypedia.com/companies/honour-lab-limited/527808a4-97a5-4c5b-8698-4dc2ab4bdeba) - [King Bio Inc.](https://www.keypedia.com/companies/king-bio-inc/bad7278d-85cb-43ee-99a5-4cb9b13a45ea) - [International Isotopes Inc.](https://www.keypedia.com/companies/international-isotopes-inc/45d80b73-be9e-40fb-978b-66683f25c070) - [Zhejiang Huahai Pharmaceutical](https://www.keypedia.com/companies/zhejiang-huahai-pharmaceutical/7742a83d-0a0c-4aed-9039-0b8b928ce70f) ## Related Officers - [company_representative](https://www.keypedia.com/people/paul-snyder/34e0a337-ab93-42fd-bead-e07e033407ad) - [company_representative](https://www.keypedia.com/people/christine-moller-jensen/41ea6b08-9b22-440a-9049-e83668cc8ee8) - [Santos E. Camara](https://www.keypedia.com/people/santos-e-camara/18cea942-f6f9-4dec-9ce9-1c01c39009ce) - [Seneca D. Toms](https://www.keypedia.com/people/seneca-d-toms/3eda62a2-4c12-438f-805a-5e3efb0f2f94) - [Medical Officer at FDA](https://www.keypedia.com/people/brittny-c-cargo/a3479241-5390-4ddb-b892-df0bac1c89cf)